Vaccine News and Research

Latest Vaccine News and Research

Pall launches PallSep Biotech filtration system

Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.

From Pall Corporation 3 Feb 2010

Study linking autism and vaccines is retracted by medical journal

The Lancet has formally retracted a controversial paper published 12 years ago that purported the measles-mumps-rubella vaccine causes autism.

3 Feb 2010

GE Healthcare expands ecomagination product portfolio, adds Centricity Enterprise EMR solution

GE Healthcare, a unit of General Electric Company, today announced that it has expanded its portfolio of ecomagination products aimed at helping healthcare companies and hospitals reduce cost and waste while positively impacting the environment. The GE ecomagination portfolio of more than 85 products now includes two new healthcare products and three product categories, including the Centricity Enterprise Electronic Medical Record (EMR) solution.

3 Feb 2010

NanoBio awarded sixth U.S. patent covering its novel nanoemulsion technology

NanoBio Corporation announced today that a sixth U.S. patent covering its novel nanoemulsion technology has been awarded. The patent encompasses composition of matter claims for the company’s lead anti-infective and vaccine product candidates.

3 Feb 2010

MV vaccine prevents TB in people with HIV infection

Results from clinical trials conducted in Tanzania show that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection. Findings from the trials, which were conducted by investigators from Dartmouth Medical School in the United States, will be published in the next issue of AIDS, the leading journal in the field of HIV and AIDS research. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

3 Feb 2010

Promising results from Soligenix' RiVax vaccine trials against ricin toxin

Soligenix, Inc., a late-stage biotechnology company, announced today the publication of an article in the February 2010 edition of Vaccine, which describes preclinical formulations of RiVax™, its ricin toxin vaccine, with heightened stability. The article was authored by the Company's collaborators at the University of Texas Southwestern Medical Center at Dallas (UT Southwestern) where the vaccine originated. RiVax™ is currently being evaluated in Phase 1 human safety and immunogenicity trials, as well as non-human primate trials for efficacy.

3 Feb 2010

CPS supports NACI recommendations for new shingles vaccine

The Canadian Pain Society (CPS) supports the National Advisory Committee on Immunization (NACI) recommendations for the use of a vaccine to significantly reduce the risk of developing herpes zoster (shingles) and post herpetic neuralgia in adults over the age of 60 without contraindications.

3 Feb 2010

PATH to pay FDA $480,000 to speed creation of pneumococcal vaccine for developing world

The FDA on Monday said it's entering into a collaboration with the nonprofit group PATH "to speed creation of a pneumococcal vaccine for children in developing nations," United Press International reports (2/1).

3 Feb 2010

Obama's FY 2011 budget gives global health funding boost

President Barack Obama's FY 2011 budget request for global health totals $9.6 billion and includes funding for global health activities within the State Department, USAID and HHS, the Wall Street Journal reports

3 Feb 2010

Obama's budget includes a tempered vision of health reform

Democrats' health overhaul efforts are stalled in Congress, but President Obama's 2011 budget offers a "modest" back-up plan, the Associated Press reports. "The budget released Monday contains lots of respectable ideas to squeeze savings, expand coverage and improve quality, but no ambitious change that launches the nation on a path to health care for all."

2 Feb 2010

Global AIDS Alliance calls for Congress to fully fund the Global Health Initiative

President Obama's budget, transmitted to Congress this morning, includes $8.5 billion for a Global Health Initiative. Based on projections to continue supporting robust U.S. programs to fight AIDS, TB and malaria and implement GHI priorities -- $16.4 billion is required in FY2011.

2 Feb 2010

Cryogenetics invents a method for cryo-preservation of fish embryos

The Norwegian company Cryogenetics Ltd. has made a significant breakthrough by inventing a method for cryo-preservation of fish embryos down to -130° C (-202° F).

2 Feb 2010

Scientists find that protease HtrA2 can "clean" cells of oncogene WT1

Dr Jorg Hartkamp and Dr Stefan Roberts have found that the protease HtrA2 can "clean" cells of the oncogene WT1, which is found at high levels in many leukaemias and solid cancers such as breast and lung cancer.

From The University of Manchester 2 Feb 2010

New therapeutic made from tobacco plants shown to arrest West Nile virus infection

A new therapeutic made from tobacco plants has been shown to arrest West Nile virus infection, according to a new study by Arizona State University scientist Qiang Chen and his colleagues.

2 Feb 2010

President's fiscal year 2011 budget: FDA requests $4.03 billion for promoting and protecting public health

The U.S. Food and Drug Administration is requesting $4.03 billion to promote and protect public health as part of the President's fiscal year 2011 budget - a 23 percent increase over the agency's current $3.28 billion budget.

2 Feb 2010

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

"We are delighted to be working with such esteemed institutions in order to generate cutting-edge therapeutic antibodies," said Matthew Baker, chief scientific officer and co-founder of Antitope. "This agreement combines our partners' expertise in novel therapeutic strategies with Antitope's expertise in engineering humanized antibodies to create therapeutic antibodies that may have a significant impact on the treatment of these major diseases."

2 Feb 2010

FDA and PATH collaborate to advance pneumococcal vaccine development for children

The U.S. Food and Drug Administration (FDA) today announced a collaboration with PATH to advance development of a vaccine to protect children against diseases caused by Streptococcus pneumoniae (pneumococcus), especially pneumonia.

2 Feb 2010

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

An experimental vaccine was found to reduce the rate of tuberculosis infections in patients living with HIV, "the first time a shot has been shown to reduce cases of the most common AIDS-related cause of death in poor nations," Bloomberg reports (Bennett, 1/29). Tuberculosis accounts for up to one-third of AIDS deaths worldwide, CBC News reports.

1 Feb 2010

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

Romark Laboratories announced that it has initiated enrollment of patients in a clinical trial of Alinia® (nitazoxanide) for treating acute uncomplicated influenza including illness caused by the currently circulating H1N1 strain.

1 Feb 2010

WHO pneumonia expert honored with PACE Global Leadership Award

WHO pneumonia expert Dr. Thomas Cherian will be honored by a group of the world’s leading infectious disease experts today for his pivotal work to accelerate access to vaccines preventing pneumococcal disease, the world’s leading vaccine-preventable killer of children under age five.

31 Jan 2010

Vaccine News and Research

Latest Vaccine News and Research

Pall launches PallSep Biotech filtration system

Study linking autism and vaccines is retracted by medical journal

GE Healthcare expands ecomagination product portfolio, adds Centricity Enterprise EMR solution

NanoBio awarded sixth U.S. patent covering its novel nanoemulsion technology

MV vaccine prevents TB in people with HIV infection

Promising results from Soligenix' RiVax vaccine trials against ricin toxin

CPS supports NACI recommendations for new shingles vaccine

PATH to pay FDA $480,000 to speed creation of pneumococcal vaccine for developing world

Obama's FY 2011 budget gives global health funding boost

Obama's budget includes a tempered vision of health reform

Global AIDS Alliance calls for Congress to fully fund the Global Health Initiative

Cryogenetics invents a method for cryo-preservation of fish embryos

Scientists find that protease HtrA2 can "clean" cells of oncogene WT1

New therapeutic made from tobacco plants shown to arrest West Nile virus infection

President's fiscal year 2011 budget: FDA requests $4.03 billion for promoting and protecting public health

BRI partners with French Government to create therapeutic antibodies for treatment of major diseases

FDA and PATH collaborate to advance pneumococcal vaccine development for children

Experimental vaccine reduced TB rate among HIV-positive people in Tanzania, Study finds

Romark Laboratories commences enrollment in Alinia clinical trial for acute uncomplicated influenza

WHO pneumonia expert honored with PACE Global Leadership Award

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in